Results

RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/SHA-384/ED506C4E6FBBB43D23DF7749A91EF3C8C3857845B4C2297055A0A4F8DD9E1404D9C3AF9F31D9D6B80BD1968046B18BF1http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/ED506C4E6FBBB43D23DF7749A91EF3C8C3857845B4C2297055A0A4F8DD9E1404D9C3AF9F31D9D6B80BD1968046B18BF1http://www.w3.org/2000/01/rdf-schema#comment"our data imply that EPHA6 expression is beneficial for glioblastoma multiforme inhibition particularly in combination with activation of BMP-2 signaling.These results suggest that EPHA6 expression or protein levels could be used as biomarkers for identification of subsets of glioblastoma multiforme patients who might benefit from BMP treatment."xsd:string
http://purl.uniprot.org/uniprot/#_3272CF637FE06BDB4E532ADBD79BB0BD2520EE4CF0D4D7199C56A4732BDAB066DDC69046F352EA9E3C10360636EB60A2http://www.w3.org/1999/02/22-rdf-syntax-ns#subjecthttp://purl.uniprot.org/SHA-384/ED506C4E6FBBB43D23DF7749A91EF3C8C3857845B4C2297055A0A4F8DD9E1404D9C3AF9F31D9D6B80BD1968046B18BF1
http://purl.uniprot.org/uniprot/Q6UWM0http://purl.uniprot.org/core/mappedAnnotationhttp://purl.uniprot.org/SHA-384/ED506C4E6FBBB43D23DF7749A91EF3C8C3857845B4C2297055A0A4F8DD9E1404D9C3AF9F31D9D6B80BD1968046B18BF1
http://purl.uniprot.org/uniprot/#_Q6UWM0-mappedCitation-31483918http://purl.uniprot.org/core/mappedAnnotationhttp://purl.uniprot.org/SHA-384/ED506C4E6FBBB43D23DF7749A91EF3C8C3857845B4C2297055A0A4F8DD9E1404D9C3AF9F31D9D6B80BD1968046B18BF1